PAPILLARY RENAL CELL CARCINOMA
Clinical trials for PAPILLARY RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PAPILLARY RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for PAPILLARY RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Looking back at cancer drugs: do they hold up in the real world?
Disease control Recruiting nowThis study aims to understand how effective and safe two existing cancer drugs, sunitinib and sorafenib, are for Chinese adults with advanced papillary kidney cancer that cannot be surgically removed. Researchers will look back at the medical records of about 150 patients who rec…
Matched conditions: PAPILLARY RENAL CELL CARCINOMA
Sponsor: AstraZeneca • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New hope for rare cancers: Triple-Threat therapy trial opens
Disease control Recruiting nowThis study is testing a combination of three drugs—cabozantinib, nivolumab, and ipilimumab—for patients with rare types of bladder, kidney, penile, and other urinary tract cancers that have spread. The goal is to see if this three-drug approach can shrink tumors and control the d…
Matched conditions: PAPILLARY RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
Three-Pronged attack on tough kidney cancers
Disease control Recruiting nowThis study is testing a combination of three drugs—bevacizumab, erlotinib, and atezolizumab—to see if they can control or shrink advanced kidney cancers linked to a hereditary condition (HLRCC) or a specific type called papillary renal cell cancer. The trial aims to enroll 65 pat…
Matched conditions: PAPILLARY RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 10, 2026 12:54 UTC
-
Scientists trace Cancer's food supply to find its weakness
Knowledge-focused Recruiting nowThis study aims to understand how kidney and bladder cancers use different nutrients from the blood to grow and survive. Researchers will give some participants a safe, specially labeled nutrient during their scheduled surgery or biopsy to track how the tumor uses it. The goal is…
Matched conditions: PAPILLARY RENAL CELL CARCINOMA
Phase: NA • Sponsor: University of Texas Southwestern Medical Center • Aim: Knowledge-focused
Last updated Apr 03, 2026 21:25 UTC